|
Starbucks sells majority stake in China business as it eyes expansion Al JazeeraStarbucks to sell control of China business to Boyu Capital in $4 billion deal CNNStarbucks to Sell 60% of Its China Business to a Private Equity Firm The New York TimesStarbucks to sell majority stake in China business BBC
|
|
Potentially huge legal issues are hovering over Kenvue. But Kimberly-Clark, which agreed to buy it for $40 billion, appears to think they're manageable.
|
|
The clash reflects the shifting landscape for weight loss and diabetes drugs, with Novo Nordisk trailing Eli Lilly as companies like Pfizer race to break in.
|
|
The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven claims from President Trump and others that use of the pain reliever during pregnancy can cause autism.
|
|
Boyu Capital will pay $4 billion for a stake in the coffee giant's 8,000 stores in China.
|
|
Kenvue's stock, which had hit a record low in recent weeks, was headed for its best day ever, while Kimberly-Clark's stock tumbled.
|
|
The move will bring 10 billion-dollar brands, including Kleenex, Band-Aid and Huggies, under one roof.
|
RELATED ARTICLES | | |
|
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.
|
|
